Status:

COMPLETED

iTBS Effect on M1 Plasticity, Blood Glucose, and Cardiovascular Response

Lead Sponsor:

Universiti Putra Malaysia

Conditions:

Healthy Young Adults

Eligibility:

All Genders

18-35 years

Phase:

NA

Brief Summary

Transcranial magnetic stimulation is a medical device that can alter motor cortical (M1) excitability through the scalp via various protocols. Among these, intermittent theta-burst stimulation (iTBS) ...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Healthy young adults (18-35 years old)
  • Right-handed
  • Fully vaccinated against COVID-19
  • Exclusion criteria:
  • Subjects with contraindications to TMS based on the screening 13-item questionnaire for TMS candidacy
  • Smokers
  • Obese (BMI ≥ 30)
  • Highly active subjects
  • Active or previous lab-confirmed COVID-19 with long symptoms

Exclusion

    Key Trial Info

    Start Date :

    July 1 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 1 2024

    Estimated Enrollment :

    18 Patients enrolled

    Trial Details

    Trial ID

    NCT06043076

    Start Date

    July 1 2023

    End Date

    January 1 2024

    Last Update

    April 2 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hospital Sultan Abdul Aziz Shah

    Serdang, Selangor, Malaysia, 43400